Skip to main content
. Author manuscript; available in PMC: 2023 Dec 22.
Published in final edited form as: J Med Chem. 2022 Dec 2;65(24):16510–16525. doi: 10.1021/acs.jmedchem.2c01380

Table 1:

Biochemical and antibacterial activity of the monovalent inhibitors

Compound IC50 (nM)a MIC (μM)b
WTc WTc +
PMBNf
ΔacrABd ΔacrABd
+ PMBNf
ΔtolCe ΔtolCe +
PMBNf
1 ≤ 1 ≥ 25 3.13 3.13 0.78 1.56 0.78
3 4.5 ± 1.8 > 25 3.13 25 0.39 1.56 0.1
9a ≤ 1 > 25 12.5 > 25 0.78 1.56 0.78
9b 19 ± 4 > 25 > 25 > 25 3.13 3.125 1.56
9c 32 ± 6 > 25 > 25 > 25 6.25 6.25 6.25
9c-p 849 ± 166 NDg NDg >25 >25 >25 >25
9d 98 ± 21 > 25 > 25 > 25 25 25 12.5
9e 82 ± 17 > 25 > 25 > 25 > 25 25 12.5
9f 64 ± 11 > 25 > 25 > 25 > 25 25 12.5
9g 126 ± 36 > 25 > 25 > 25 > 25 > 25 12.5
14 74 ± 12 > 25 12.5 > 25 1.56 1.56 0.2
a

ACC activity was determined using a fluorescence polarization assay. Reactions were performed in triplicate and the errors are standard deviation from the mean.

b

MIC values were determined by the microbroth dilution method. Experiments were performed in triplicate.

c

Wild-type, E. coli strain (K-12, MG1655).

d

E. coli ΔacrAB, knockout of the acrAB inner efflux pump.

e

E. coli ΔtolC, knockout of the tolC outer efflux pump.

f

PMBN was present at final concentration of 6 μM (8 μg/mL).

g

ND, not determined.